Filtros de búsqueda

Lista de obras de L Bertani

A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up

artículo científico publicado en 2020

Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care

artículo científico publicado en 2020

Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

scientific article published on 06 February 2020

Association between baseline impedance values and response proton pump inhibitors in patients with heartburn

artículo científico publicado en 2014

Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis

artículo científico publicado en 2019

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

scientific article published on 03 September 2019

Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply

artículo científico publicado en 2021

Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab-authors' reply

artículo científico publicado en 2020

Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease

artículo científico publicado en 2017

Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases

scientific article published on 24 October 2019

Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.

artículo científico publicado en 2016

Irritable bowel syndrome and chronic constipation: Fact and fiction

artículo científico publicado en 2015

Letter: ustekinumab's effectiveness outcomes compared with vedolizumab in Crohn's disease-what about mucosal healing and biomarkers?

artículo científico publicado en 2020

Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome?

artículo científico publicado en 2020

Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.

artículo científico publicado en 2014

Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring.

artículo científico publicado en 2015

Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?

artículo científico publicado en 2013

Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab

artículo científico publicado en 2020

Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients

artículo científico publicado en 2020

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

artículo científico publicado en 2018

Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda